Liposome Drug Delivery (Liposomes Drug Delivery) Market Report

Global and Region Liposome Drug Delivery (Liposomes Drug Delivery) Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Aug 01, 2022
  • PAGES：166
  • REPORT CODE：GMM960265
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Liposomes have been used to improve the therapeutic index of new or established drugs by modifying drug absorption, reducing metabolism, prolonging biological half-life or reducing toxicity. Drug distribution is then controlled primarily by properties of the carrier and no longer by physico-chemical characteristics of the drug substance only.

    In the last several years, the development of Liposomes Drug Delivery market is fast with an average growth rate of 13.52%. In 2017, the global revenue of Liposomes Drug Delivery market is nearly 2.30 billion USD.North America dominated the market with market share of 42.44% due to the high medical level. Following North America, Europe is the second largest market with market share of 32.33%. Asian Pacific regions are the third largest market with developed countries like Japan and many developing countries like China. Its market share is about 23.81%.

    The report details the trend, potential and market size of Liposome Drug Delivery (Liposomes Drug Delivery) market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Liposome Drug Delivery (Liposomes Drug Delivery)market, defines the market attractiveness level of Liposome Drug Delivery (Liposomes Drug Delivery) market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Liposome Drug Delivery (Liposomes Drug Delivery) industry, describes the types of Liposome Drug Delivery (Liposomes Drug Delivery) market, the applications of major players and the market size, and deeply analyzes the current situation of the global Liposome Drug Delivery (Liposomes Drug Delivery) market and the development prospects and opportunities of Liposome Drug Delivery (Liposomes Drug Delivery) industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Liposome Drug Delivery (Liposomes Drug Delivery) market in Chapter 13.

    By Player:

    • Luye Pharma

    • Novartis

    • Pacira

    • Fudan-Zhangjiang

    • CSPC

    • Gilead Sciences

    • Teva Pharmaceutical

    • Sun Pharmaceutical

    • Johnson & Johnson

    • Sigma-Tau Group

    • Ipsen (Onivyde)

    By Type:

    • Liposomal Doxorubicin

    • Liposomal Amphoteracin B

    • Liposomal Paclitaxel

    • Others

    By End-User:

    • Fungal Infection Therapy

    • Cancer & Tumor Therapy

    • Others

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Liposome Drug Delivery (Liposomes Drug Delivery) Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Liposome Drug Delivery (Liposomes Drug Delivery) Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Liposome Drug Delivery (Liposomes Drug Delivery) Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Liposome Drug Delivery (Liposomes Drug Delivery) Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Liposome Drug Delivery (Liposomes Drug Delivery) Market Analysis and Outlook to 2022

    • 7.1 Global Liposome Drug Delivery (Liposomes Drug Delivery) Consumption (2017-2022)

    • 7.2 United States Liposome Drug Delivery (Liposomes Drug Delivery) Consumption (2017-2022)

    • 7.3 Europe Liposome Drug Delivery (Liposomes Drug Delivery) Consumption (2017-2022)

    • 7.4 China Liposome Drug Delivery (Liposomes Drug Delivery) Consumption (2017-2022)

    • 7.5 Japan Liposome Drug Delivery (Liposomes Drug Delivery) Consumption (2017-2022)

    • 7.6 India Liposome Drug Delivery (Liposomes Drug Delivery) Consumption (2017-2022)

    • 7.7 South Korea Liposome Drug Delivery (Liposomes Drug Delivery) Consumption (2017-2022)

    8 Region and Country-wise Liposome Drug Delivery (Liposomes Drug Delivery) Market Analysis and Outlook to 2028

    • 8.1 Global Liposome Drug Delivery (Liposomes Drug Delivery) Consumption Forecast (2022-2028)

    • 8.2 United States Liposome Drug Delivery (Liposomes Drug Delivery) Consumption Forecast (2022-2028)

    • 8.3 Europe Liposome Drug Delivery (Liposomes Drug Delivery) Consumption Forecast (2022-2028)

    • 8.4 China Liposome Drug Delivery (Liposomes Drug Delivery) Consumption Forecast (2022-2028)

    • 8.5 Japan Liposome Drug Delivery (Liposomes Drug Delivery) Consumption Forecast (2022-2028)

    • 8.6 India Liposome Drug Delivery (Liposomes Drug Delivery) Consumption Forecast (2022-2028)

    • 8.7 South Korea Liposome Drug Delivery (Liposomes Drug Delivery) Consumption Forecast (2022-2028)

    9 Global Liposome Drug Delivery (Liposomes Drug Delivery) Market Outlook by Types and Applications to 2022

    • 9.1 Global Liposome Drug Delivery (Liposomes Drug Delivery) Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Liposomal Doxorubicin Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Liposomal Amphoteracin B Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Liposomal Paclitaxel Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Others Consumption and Growth Rate (2017-2022)

    • 9.2 Global Liposome Drug Delivery (Liposomes Drug Delivery) Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Fungal Infection Therapy Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Cancer & Tumor Therapy Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Others Consumption and Growth Rate (2017-2022)

    10 Global Liposome Drug Delivery (Liposomes Drug Delivery) Market Outlook by Types and Applications to 2028

    • 10.1 Global Liposome Drug Delivery (Liposomes Drug Delivery) Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Liposomal Doxorubicin Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Liposomal Amphoteracin B Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Liposomal Paclitaxel Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global Others Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Liposome Drug Delivery (Liposomes Drug Delivery) Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Fungal Infection Therapy Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Cancer & Tumor Therapy Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)

    11 Global Liposome Drug Delivery (Liposomes Drug Delivery) Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Liposome Drug Delivery (Liposomes Drug Delivery) Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Liposome Drug Delivery (Liposomes Drug Delivery) Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Liposome Drug Delivery (Liposomes Drug Delivery) Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Liposome Drug Delivery (Liposomes Drug Delivery) Market Competitive Analysis

    • 14.1 Luye Pharma

      • 14.1.1 Luye Pharma Company Details

      • 14.1.2 Luye Pharma Liposome Drug Delivery (Liposomes Drug Delivery) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Luye Pharma Liposome Drug Delivery (Liposomes Drug Delivery) Product and Service

    • 14.2 Novartis

      • 14.2.1 Novartis Company Details

      • 14.2.2 Novartis Liposome Drug Delivery (Liposomes Drug Delivery) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Novartis Liposome Drug Delivery (Liposomes Drug Delivery) Product and Service

    • 14.3 Pacira

      • 14.3.1 Pacira Company Details

      • 14.3.2 Pacira Liposome Drug Delivery (Liposomes Drug Delivery) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Pacira Liposome Drug Delivery (Liposomes Drug Delivery) Product and Service

    • 14.4 Fudan-Zhangjiang

      • 14.4.1 Fudan-Zhangjiang Company Details

      • 14.4.2 Fudan-Zhangjiang Liposome Drug Delivery (Liposomes Drug Delivery) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Fudan-Zhangjiang Liposome Drug Delivery (Liposomes Drug Delivery) Product and Service

    • 14.5 CSPC

      • 14.5.1 CSPC Company Details

      • 14.5.2 CSPC Liposome Drug Delivery (Liposomes Drug Delivery) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 CSPC Liposome Drug Delivery (Liposomes Drug Delivery) Product and Service

    • 14.6 Gilead Sciences

      • 14.6.1 Gilead Sciences Company Details

      • 14.6.2 Gilead Sciences Liposome Drug Delivery (Liposomes Drug Delivery) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Gilead Sciences Liposome Drug Delivery (Liposomes Drug Delivery) Product and Service

    • 14.7 Teva Pharmaceutical

      • 14.7.1 Teva Pharmaceutical Company Details

      • 14.7.2 Teva Pharmaceutical Liposome Drug Delivery (Liposomes Drug Delivery) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Teva Pharmaceutical Liposome Drug Delivery (Liposomes Drug Delivery) Product and Service

    • 14.8 Sun Pharmaceutical

      • 14.8.1 Sun Pharmaceutical Company Details

      • 14.8.2 Sun Pharmaceutical Liposome Drug Delivery (Liposomes Drug Delivery) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Sun Pharmaceutical Liposome Drug Delivery (Liposomes Drug Delivery) Product and Service

    • 14.9 Johnson & Johnson

      • 14.9.1 Johnson & Johnson Company Details

      • 14.9.2 Johnson & Johnson Liposome Drug Delivery (Liposomes Drug Delivery) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Johnson & Johnson Liposome Drug Delivery (Liposomes Drug Delivery) Product and Service

    • 14.10 Sigma-Tau Group

      • 14.10.1 Sigma-Tau Group Company Details

      • 14.10.2 Sigma-Tau Group Liposome Drug Delivery (Liposomes Drug Delivery) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Sigma-Tau Group Liposome Drug Delivery (Liposomes Drug Delivery) Product and Service

    • 14.11 Ipsen (Onivyde)

      • 14.11.1 Ipsen (Onivyde) Company Details

      • 14.11.2 Ipsen (Onivyde) Liposome Drug Delivery (Liposomes Drug Delivery) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 Ipsen (Onivyde) Liposome Drug Delivery (Liposomes Drug Delivery) Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Liposome Drug Delivery (Liposomes Drug Delivery)

    • Figure Liposome Drug Delivery (Liposomes Drug Delivery) Picture

    • Table Global Liposome Drug Delivery (Liposomes Drug Delivery) Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Liposome Drug Delivery (Liposomes Drug Delivery) Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Liposome Drug Delivery (Liposomes Drug Delivery) Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Liposome Drug Delivery (Liposomes Drug Delivery) Consumption by Country (2017-2022)

    • Figure United States Liposome Drug Delivery (Liposomes Drug Delivery) Consumption and Growth Rate (2017-2022)

    • Table Europe Liposome Drug Delivery (Liposomes Drug Delivery) Consumption and Growth Rate (2017-2022)

    • Figure China Liposome Drug Delivery (Liposomes Drug Delivery) Consumption and Growth Rate (2017-2022)

    • Figure Japan Liposome Drug Delivery (Liposomes Drug Delivery) Consumption and Growth Rate (2017-2022)

    • Figure India Liposome Drug Delivery (Liposomes Drug Delivery) Consumption and Growth Rate (2017-2022)

    • Figure South Korea Liposome Drug Delivery (Liposomes Drug Delivery) Consumption and Growth Rate (2017-2022)

    • Figure Global Liposome Drug Delivery (Liposomes Drug Delivery) Consumption Forecast by Country (2022-2028)

    • Figure United States Liposome Drug Delivery (Liposomes Drug Delivery) Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Liposome Drug Delivery (Liposomes Drug Delivery) Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Liposome Drug Delivery (Liposomes Drug Delivery) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Liposome Drug Delivery (Liposomes Drug Delivery) Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Liposome Drug Delivery (Liposomes Drug Delivery) Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Liposome Drug Delivery (Liposomes Drug Delivery) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Liposomal Doxorubicin Consumption and Growth Rate (2017-2022)

    • Figure Global Liposomal Amphoteracin B Consumption and Growth Rate (2017-2022)

    • Figure Global Liposomal Paclitaxel Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Fungal Infection Therapy Consumption and Growth Rate (2017-2022)

    • Figure Global Cancer & Tumor Therapy Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Liposomal Doxorubicin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Liposomal Amphoteracin B Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Liposomal Paclitaxel Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Fungal Infection Therapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Cancer & Tumor Therapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Liposome Drug Delivery (Liposomes Drug Delivery) Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Liposome Drug Delivery (Liposomes Drug Delivery) Export by Region (Top 5 Countries) (2017-2028)

    • Table Luye Pharma (Foundation Year, Company Profile and etc.)

    • Table Luye Pharma Liposome Drug Delivery (Liposomes Drug Delivery) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Luye Pharma Liposome Drug Delivery (Liposomes Drug Delivery) Product and Service

    • Table Novartis (Foundation Year, Company Profile and etc.)

    • Table Novartis Liposome Drug Delivery (Liposomes Drug Delivery) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis Liposome Drug Delivery (Liposomes Drug Delivery) Product and Service

    • Table Pacira (Foundation Year, Company Profile and etc.)

    • Table Pacira Liposome Drug Delivery (Liposomes Drug Delivery) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pacira Liposome Drug Delivery (Liposomes Drug Delivery) Product and Service

    • Table Fudan-Zhangjiang (Foundation Year, Company Profile and etc.)

    • Table Fudan-Zhangjiang Liposome Drug Delivery (Liposomes Drug Delivery) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Fudan-Zhangjiang Liposome Drug Delivery (Liposomes Drug Delivery) Product and Service

    • Table CSPC (Foundation Year, Company Profile and etc.)

    • Table CSPC Liposome Drug Delivery (Liposomes Drug Delivery) Sales, Price, Value and Gross Profit (2017-2022)

    • Table CSPC Liposome Drug Delivery (Liposomes Drug Delivery) Product and Service

    • Table Gilead Sciences (Foundation Year, Company Profile and etc.)

    • Table Gilead Sciences Liposome Drug Delivery (Liposomes Drug Delivery) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Gilead Sciences Liposome Drug Delivery (Liposomes Drug Delivery) Product and Service

    • Table Teva Pharmaceutical (Foundation Year, Company Profile and etc.)

    • Table Teva Pharmaceutical Liposome Drug Delivery (Liposomes Drug Delivery) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Teva Pharmaceutical Liposome Drug Delivery (Liposomes Drug Delivery) Product and Service

    • Table Sun Pharmaceutical (Foundation Year, Company Profile and etc.)

    • Table Sun Pharmaceutical Liposome Drug Delivery (Liposomes Drug Delivery) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sun Pharmaceutical Liposome Drug Delivery (Liposomes Drug Delivery) Product and Service

    • Table Johnson & Johnson (Foundation Year, Company Profile and etc.)

    • Table Johnson & Johnson Liposome Drug Delivery (Liposomes Drug Delivery) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Johnson & Johnson Liposome Drug Delivery (Liposomes Drug Delivery) Product and Service

    • Table Sigma-Tau Group (Foundation Year, Company Profile and etc.)

    • Table Sigma-Tau Group Liposome Drug Delivery (Liposomes Drug Delivery) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sigma-Tau Group Liposome Drug Delivery (Liposomes Drug Delivery) Product and Service

    • Table Ipsen (Onivyde) (Foundation Year, Company Profile and etc.)

    • Table Ipsen (Onivyde) Liposome Drug Delivery (Liposomes Drug Delivery) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Ipsen (Onivyde) Liposome Drug Delivery (Liposomes Drug Delivery) Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US